Autonomic Nervous System Drugs Practice Questions

Q: Gallamine is primarily excreted through which organ?

Kidney. **Explanation:** **Gallamine** is a long-acting, non-depolarizing neuromuscular blocking agent (NMBA). The correct answer is **Kidney** because Gallamine is unique among muscle relaxants for being almost entirely (approximately 95–100%) dependent on renal excretion for its elimination from the body. * **Why Kidney is correct:** Since Gallamine is not metabolized by the liver or plasma enzymes, its clearance relies solely on glomerular filtration. In patients with renal failure, the elimination half-life is significantly prolonged, leading to a high risk of "recurarization" and prolonged neuromuscular blockade. * **Why Bile/Liver are incorrect:** Unlike drugs like Vecuronium or Rocuronium, which undergo significant hepatic metabolism and biliary excretion, Gallamine undergoes no metabolic transformation in the liver. * **Why Pseudocholinesterase is incorrect:** This enzyme is responsible for the metabolism of Succinylcholine and Mivacurium. Gallamine is a synthetic gallic acid derivative and is not a substrate for cholinesterases. **High-Yield Clinical Pearls for NEET-PG:** * **Vagolytic Effect:** Gallamine is notorious for causing significant **tachycardia** due to its strong antimuscarinic (vagolytic) action on the M2 receptors of the heart. * **Contraindication:** It is strictly contraindicated in patients with **renal impairment** due to the risk of profound, irreversible paralysis. * **Historical Context:** While largely replaced by newer agents like Cisatracurium (which uses Organ-independent Hofmann elimination), it remains a classic exam topic regarding drug elimination routes.

Q: Vagal stimulation causes bradycardia, which can be blocked by?

atropine. **Explanation:** The correct answer is **Atropine**. **Mechanism of Action:** Vagal stimulation (parasympathetic activity) leads to the release of **Acetylcholine (ACh)** at the sinoatrial (SA) node. ACh binds to **Muscarinic M2 receptors**, which are G-protein coupled receptors (Gi). This action decreases cAMP, opens potassium channels (hyperpolarization), and decreases the firing rate of the SA node, resulting in **bradycardia**. **Atropine** is a competitive antagonist of muscarinic receptors. By blocking the M2 receptors in the heart, it prevents ACh from binding, thereby inhibiting the vagal effect and increasing the heart rate (tachycardia). **Analysis of Incorrect Options:** * **A. Atenolol:** A selective $\beta_1$-blocker. It decreases heart rate by blocking sympathetic input. It would exacerbate bradycardia rather than block the vagal effect. * **C. Doxazosin:** A selective $\alpha_1$-blocker used primarily for hypertension and BPH. It acts on vascular smooth muscle and has no significant effect on vagal-mediated heart rate changes. * **D. Phenylephrine:** A selective $\alpha_1$-agonist. It causes vasoconstriction, which actually triggers a **reflex bradycardia** via the baroreceptor reflex (increased vagal tone). **NEET-PG High-Yield Pearls:** * **Drug of Choice:** Atropine is the first-line treatment for hemodynamically unstable sinus bradycardia. * **Paradoxical Effect:** Low doses of atropine can cause transient "paradoxical bradycardia" due to the blockade of presynaptic inhibitory M1 receptors on vagal nerve endings. * **Vagal Escape:** If the ventricles start beating at their own intrinsic rhythm during prolonged vagal stimulation, it is termed "vagal escape."

Q: Which class of autonomic drugs is used for reversing skeletal muscle relaxation caused by a nondepolarizing blocker?

Cholinesterase inhibitors. **Explanation:** **Mechanism of Action (Why A is correct):** Nondepolarizing neuromuscular blockers (e.g., Vecuronium, Rocuronium) act as competitive antagonists at the nicotinic acetylcholine receptors ($N_m$) on the motor endplate. To reverse their effect, the concentration of endogenous acetylcholine (ACh) must be increased at the neuromuscular junction to outcompete the blocker. **Cholinesterase inhibitors** (specifically reversible ones like **Neostigmine**) achieve this by inhibiting the enzyme acetylcholinesterase, preventing the breakdown of ACh. This surge in ACh restores normal muscle contraction. **Analysis of Incorrect Options:** * **B & C (Parasympatholytics / Muscarinic antagonists):** These terms are often used interchangeably (e.g., Atropine). They block muscarinic receptors, not nicotinic receptors. While they are administered *alongside* Neostigmine to prevent unwanted bradycardia and salivation, they do not reverse muscle paralysis themselves. * **D (Sympatholytics):** These drugs (e.g., Beta-blockers) inhibit the sympathetic nervous system. They have no direct effect on the neuromuscular junction or the reversal of skeletal muscle relaxation. **High-Yield Clinical Pearls for NEET-PG:** * **The "Atropine Rule":** Neostigmine must always be co-administered with a muscarinic antagonist (Atropine or Glycopyrrolate) to counteract the systemic parasympathetic side effects (bradycardia, bronchospasm, increased secretions) caused by excess ACh. * **Edrophonium:** A rapid-acting cholinesterase inhibitor used in the **Tensilon test** for Myasthenia Gravis, but less commonly used for surgical reversal due to its short duration. * **Sugammadex:** A newer, non-cholinesterase inhibitor agent that reverses Rocuronium/Vecuronium by direct encapsulation (chelation).

Q: A patient presented to casualty with acute bronchial asthma after receiving treatment for glaucoma. What is the probable drug that caused this?

Timolol. **Explanation:** **1. Why Timolol is Correct:** Timolol is a **non-selective beta-blocker** ($\beta_1$ and $\beta_2$ antagonist) commonly used as first-line topical therapy for open-angle glaucoma to decrease aqueous humor production. Even when administered as eye drops, systemic absorption via the nasolacrimal duct can occur. In patients with reactive airway disease, the blockade of **$\beta_2$ receptors** in the bronchial smooth muscle leads to bronchoconstriction, which can precipitate a life-threatening acute asthma attack. **2. Why the Other Options are Incorrect:** * **Betaxolol:** This is a **cardioselective ($\beta_1$) blocker**. While no beta-blocker is 100% selective, Betaxolol is significantly safer for the lungs than Timolol and is the preferred beta-blocker for glaucoma patients with co-existing respiratory issues. * **Latanoprost:** A Prostaglandin $F_{2\alpha}$ analog. Its primary side effects are local (increased iris pigmentation, eyelash growth, and conjunctival hyperemia). It does not cause bronchospasm. * **Anticholinesterases:** (e.g., Physostigmine, Echothiophate) These are miotics. While they can cause systemic cholinergic side effects (SLUDGE), they are rarely used today and are not the classic "culprit" for sudden asthma exacerbations in glaucoma therapy compared to beta-blockers. **3. High-Yield Clinical Pearls for NEET-PG:** * **Systemic Absorption:** To minimize systemic side effects of glaucoma drops, patients should be taught **nasolacrimal occlusion** (pressing the inner corner of the eye) for 1–2 minutes after instillation. * **Contraindications for Timolol:** Asthma, COPD, Bradycardia, and $2^{nd}$ or $3^{rd}$-degree Heart Block. * **Drug of Choice:** Latanoprost is currently the overall DOC for Open Angle Glaucoma, but Timolol remains a high-yield topic for its side-effect profile.

Q: Which of the following is NOT a direct effect of acetylcholine?

Increase in heart contraction. **Explanation:** Acetylcholine (ACh) is the primary neurotransmitter of the parasympathetic nervous system, acting on **muscarinic (M) receptors** in the heart and vasculature. **Why "Increase in heart contraction" is the correct answer:** Acetylcholine exerts a **negative inotropic effect** (decreased force of contraction). In the heart, ACh binds to **M2 receptors** (G_i coupled), which leads to a decrease in cAMP levels. This results in a decrease in the force of contraction, particularly in the atria. It does **not** increase heart contraction; that is a sympathetic effect mediated by Beta-1 receptors. **Analysis of incorrect options:** * **A. Decrease in blood pressure:** ACh causes vasodilation by acting on **M3 receptors** on vascular endothelial cells. This triggers the release of **Nitric Oxide (EDRF)**, which relaxes vascular smooth muscle, leading to a fall in BP. * **C. Decrease in heart rate:** ACh acts on M2 receptors at the SA node to increase K+ conductance and decrease cAMP, leading to hyperpolarization. This results in a **negative chronotropic effect** (bradycardia). * **D. Decrease in conduction velocity:** ACh slows conduction through the AV node (a **negative dromotropic effect**), which increases the PR interval on an ECG. **NEET-PG High-Yield Pearls:** 1. **Vascular Paradox:** Blood vessels lack parasympathetic innervation, but they *do* possess M3 receptors. Therefore, exogenous ACh causes vasodilation, but vagal stimulation does not significantly affect BP. 2. **M2 Receptors:** Located in the heart (Atria > Ventricles). They are G_i protein-coupled. 3. **Atropine:** The drug of choice to reverse the bradycardia and AV block caused by excessive cholinergic activity.

Q: Which muscle is affected last by d-tubocurarine?

Diaphragm. ### Explanation The sequence of muscle paralysis by competitive neuromuscular blockers (like **d-tubocurarine**) follows a specific pattern based on muscle size, blood flow, and metabolic activity. **1. Why the Diaphragm is correct:** The **diaphragm** is the most resistant muscle to non-depolarizing neuromuscular blockers. It has a high density of nicotinic receptors and a very high blood flow, which allows it to maintain function longer than peripheral muscles. Consequently, it is the **last muscle to be paralyzed** and the **first to recover** once the drug effects wear off. This is a crucial safety mechanism in anesthesia. **2. Analysis of Incorrect Options:** * **C. Ocular muscles:** These are the **first** to be affected. Small, rapidly moving muscles (like those of the eyes, fingers, and jaw) are highly sensitive to blockade. * **A. Facial muscles:** These are affected shortly after the ocular muscles, following the "small-to-large" muscle progression. * **D. Abdominal muscles:** These are large trunk muscles. While they are paralyzed before the diaphragm, they are affected later than the small muscles of the face and limbs. **3. NEET-PG High-Yield Pearls:** * **Sequence of Paralysis:** Small muscles (Eyes/Face) → Limbs/Trunk → Intercostal muscles → Diaphragm. * **Sequence of Recovery:** Exactly the reverse (Diaphragm recovers first). * **Mechanism:** d-tubocurarine is a prototype non-depolarizing blocker that acts as a competitive antagonist at **Nm receptors**. * **Clinical Sign:** "Curarization" refers to the state of paralysis; "Decurarization" is the reversal, typically achieved using an acetylcholinesterase inhibitor like **Neostigmine** (combined with Glycopyrrolate to prevent muscarinic side effects).

Q: Beta-blockers mask all the symptoms of hypoglycemia except which one?

Sweating. **Explanation:** Hypoglycemia triggers a massive sympathetic (autonomic) surge, leading to symptoms such as tachycardia, palpitations, tremors, and anxiety. These symptoms are primarily mediated by **$\beta_1$ and $\beta_2$ adrenergic receptors**. **1. Why Sweating is the Correct Answer:** Sweating (diaphoresis) is the only sympathetic symptom of hypoglycemia that remains unmasked by beta-blockers. This is because the postganglionic sympathetic fibers innervating sweat glands are **cholinergic** (they release Acetylcholine acting on Muscarinic receptors), not adrenergic. Since beta-blockers only antagonize adrenergic receptors, they have no effect on the cholinergic pathway responsible for sweating. **2. Why the Other Options are Incorrect:** * **Increased heart rate (Tachycardia):** This is mediated by $\beta_1$ receptors in the heart. Beta-blockers effectively block these receptors, preventing the compensatory rise in heart rate during hypoglycemia. * **Hypertension/Tremors/Palpitations:** These are also mediated by adrenergic receptors ($\beta_1$ and $\beta_2$). Beta-blockers suppress these "warning signs," which can lead to "hypoglycemia unawareness"—a dangerous clinical state. **Clinical Pearls for NEET-PG:** * **The "Masking" Effect:** Beta-blockers are used with extreme caution in diabetic patients because they hide the early warning signs of hypoglycemia, except for sweating. * **The "Pressor" Effect:** In hypoglycemia, there is a massive release of Epinephrine. If a non-selective beta-blocker (like Propranolol) is used, $\beta_2$-mediated vasodilation is blocked, leaving **$\alpha_1$-mediated vasoconstriction unopposed**. This can lead to a paradoxical, severe hypertensive crisis. * **Metabolic Impact:** Beta-blockers also inhibit glycogenolysis and gluconeogenesis (mediated by $\beta_2$ receptors), which can delay recovery from a hypoglycemic episode.

Q: Side effects of timolol maleate include:

All of these. **Explanation:** Timolol maleate is a **non-selective beta-adrenergic antagonist** (blocking both $\beta_1$ and $\beta_2$ receptors) commonly used as first-line therapy for glaucoma. Despite being administered topically, it undergoes significant systemic absorption through the nasolacrimal duct, bypassing first-pass metabolism. This can lead to systemic side effects similar to oral beta-blockers. * **Asthma (Option A):** By blocking $\beta_2$ receptors in the bronchi, timolol causes bronchoconstriction. It is strictly contraindicated in patients with bronchial asthma or severe COPD. * **Depression (Option B):** Beta-blockers are lipophilic and can cross the blood-brain barrier, leading to central nervous system side effects such as depression, fatigue, confusion, and sleep disturbances. * **Hypotension (Option C):** By blocking $\beta_1$ receptors in the heart, timolol reduces cardiac output (negative inotropic and chronotropic effects), leading to bradycardia, hypotension, and potential heart block. Since timolol can trigger all the aforementioned systemic complications, **Option D (All of these)** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Betaxolol** is a cardioselective ($\beta_1$) blocker and is the safest topical beta-blocker for patients with respiratory issues (though caution is still advised). * **Nasolacrimal occlusion (NLO):** Instructing patients to apply pressure over the lacrimal sac for 2 minutes after instillation reduces systemic absorption and side effects. * **Contraindications:** Always screen for bradycardia, heart block, and asthma before prescribing Timolol.

Question 1

Patients taking a beta-adrenergic receptor blocking drug may experience all of the following except:

Accepted Answer

Nasal blockage

Answer

Exacerbation of existing heart block

Answer

Precipitation of heart failure

Answer

Cold extremities

Question 2

Gallamine is primarily excreted through which organ?

Accepted Answer

Kidney

Answer

Bile

Answer

Liver

Answer

Pseudocholinesterase

Question 3

Vagal stimulation causes bradycardia, which can be blocked by?

Accepted Answer

atropine

Answer

atenolol

Answer

doxazosin

Answer

phenylephrine

Question 4

Which class of autonomic drugs is used for reversing skeletal muscle relaxation caused by a nondepolarizing blocker?

Accepted Answer

Cholinesterase inhibitors

Answer

Parasympatholytics

Answer

Muscarinic antagonists

Answer

Sympatholytics

Question 5

A patient presented to casualty with acute bronchial asthma after receiving treatment for glaucoma. What is the probable drug that caused this?

Accepted Answer

Timolol

Answer

Betaxolol

Answer

Latanoprost

Answer

Anticholinesterase

Question 6

An antimuscarinic drug is being considered for the treatment of an 80-year-old patient. Atropine therapy in the elderly may be hazardous because:

Accepted Answer

Atropine can elevate intraocular pressure in patients with glaucoma

Answer

Atropine frequently causes ventricular tachycardia

Answer

Urinary retention may be precipitated by atropine in women

Answer

The elderly are particularly prone to develop dangerous hyperthermia when given Atropine

Question 7

Which of the following is NOT a direct effect of acetylcholine?

Accepted Answer

Increase in heart contraction

Answer

Decrease in blood pressure

Answer

Decrease in heart rate

Answer

Decrease in conduction velocity

Question 8

Which muscle is affected last by d-tubocurarine?

Accepted Answer

Diaphragm

Answer

Facial muscles

Answer

Ocular muscles

Answer

Abdominal muscles

Question 9

Beta-blockers mask all the symptoms of hypoglycemia except which one?

Accepted Answer

Sweating

Answer

Increased heart rate

Answer

Hypertension

Answer

None of the above

Question 10

Side effects of timolol maleate include:

Accepted Answer

All of these

Answer

Asthma

Answer

Depression

Answer

Hypotension

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?